Azenta, Inc. announced the launch of the Cryo Store Pico, a novel automated cryogenic storage system designed for high-value biological samples used in the...
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, announced...
Nuevocor, a pre-clinical stage cardiac gene therapy company, announced that it will present new preclinical data on its adeno-associated virus (AAV) gene therapy for...
On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor...
bluebird bio, Inc. announced the outcome of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) discussion of...
